Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KEY vs GSK✓SelectedUSD · GSKKEY vs GSK performance historyLatest closeAs of-1.07%11/16
Stock and ETF performance explorer

KEY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+29.1%
GSK return
+9.7%
Excess return
+19.4%
Maximum drawdown
-17.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.1%-0.1%-1.0%-1.1%
7D-0.8%-1.3%+0.5%-0.6%
30D+6.2%+2.7%+3.5%+5.7%
3M-8.1%+2.7%-10.8%-8.6%
6M+2.9%+3.3%-0.5%+1.9%
YTD+5.9%+6.5%-0.6%+5.9%
All+29.1%+9.7%+19.4%+28.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling